Resolutions from the Annual General Meeting of Novo Nordisk A/S
27/3 16:17
Bagsværd, Denmark, 27 March 2025 – Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, chair of the Board of Directors communicated: “2024 was another year of significant growth for Novo Nordisk, characterised by continued innovation, capacity expansions and commercial execution. Our industry-leading therapeutic innovations benefited more than 45 […]...